Skip to content

Treating Prolonged Grief Disorder with Prolonged Grief-Specific Cognitive Behavioral Therapy: A Multicenter Parallel Group Randomized Controlled Trial

Treating Prolonged Grief Disorder with Prolonged Grief-Specific Cognitive Behavioral Therapy: A Multicenter Parallel Group Randomized Controlled Trial - PROGRID

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00012317
Enrollment
204
Registered
2017-09-06
Start date
2017-10-26
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Prolonged grief disorder (PGD) – expected to be included in ICD-11 (see beta version: http://bit.ly/1GoZamZ)

Interventions

Group 1: 20 to 24 individual sessions of integrative cognitive behavioral therapy for prolonged grief (PG-CBT
Pfoh, Kotoucová & Rosner, 2015). Sessions are scheduled weekly whenever possible, a session lasting 50 minutes, although some sessions can be combined (100 min). The overall length of treatment is abo
Schnurr, Friedman, Foy et al., 2003
Shea, Bernardy, Howard, Key, & Lambert, 2003). Sessions are scheduled weekly whenever possible, a session lasting 50 minutes, although some sessions can be combined (100 min). The overall length of tr

Sponsors

Katholische Universität Eichstätt-Ingolstadt
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: - primary diagnosis of prolonged grief disorder (PGD) as assessed in the PG-13 interview (Prigerson, Horowitz, Jacobs et al., 2009; German version: Rosner, Pfoh & Kotoucová, 2015) - sufficient cognitive skills - sufficient German language skills - informed consent

Exclusion criteria

Exclusion criteria: - current psychotic disorder - severe substance use disorder - acute suicidality - ongoing psychotherapy - treatment regime for antidepressant medication not yet stable for four weeks - continuous treatment with benzodiazepines, antipsychotics, or opioids - participation in another treatment trial

Design outcomes

Primary

MeasureTime frame
Severity of prolonged grief symptoms 12 months after randomization, measured with the German version (Rosner, Pfoh & Kotoucová, 2015) of the Interview for Prolonged Grief-13 (PG-13; Prigerson, Horowitz, Jacobs et al., 2009)

Secondary

MeasureTime frame
Post-treatment: Prolonged grief symptom severity, measured with the German version (Rosner, Pfoh & Kotoucová, 2015) of the Interview for Prolonged Grief-13 (PG-13; Prigerson, Horowitz, Jacobs et al., 2009) 12 months after randomization and post-treatment: • overall mental health, measured with the Global Severity Index (GSI) of the German version of the Brief Symptom Inventory (BSI; Franke, 2000) • depressive symptoms, measured with the German revised version of the Beck Depression Inventory (BDI-II; Hautzinger, Keller, & Kühner, 2009) • severity of somatoform symptoms according to the SOMS-7 (Rief & Hiller, 2008)

Countries

Germany

Contacts

Public ContactAnna-Maria Rummel

Katholische Universität Eichstätt-Ingolstadt, Lehrstuhl für Klinische und Biologische Psychologie

Anna-Maria.Rummel@ku.de+49 0841 937 - 21622

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Mar 6, 2026